Database Solutions
Beacon Database Solutions

Access exclusive datasets of pre-clinical, clinical and commercial data for complex therapeutics.

Complete with granular proprietary ontologies for precision searching and filtering.
Modalities

ADC

Bispecific

DDR

Cell Therapy

Cancer Vaccine

Microbiome

Gene Therapy

Checkpoint

Oncolytic Viruses

RNA

Cytokine

TPD
Disease Areas

Oncology

Neuroscience

Neurology

Psychiatric

Autoimmune
Services
Beacon Services

Beacon APIs enable you to integrate Beacon data into your internal systems and dashboards.

Hanson Wade Intelligence provides bespoke market research and consultancy services.
APIs

Technology Plus

Benchmarking & Pipeline Prioritization

Client Finder

Competitive Landscape

Service Alignment

Strategic Partnerships, Licensing & Acquisitions

API Use Cases
Market Research

Hanson Wade Intelligence
Our Data
Beacon Data

Beacon data is manually curated by sector specialist analysts, to ensure unrivalled accuracy and comprehensiveness.
Our Data

Drug Data

Trial Data

Company Data

Deal Data

Patent Data
Resources
Beacon Resources

Our resources offer strategic insight into the drug, trial and commercial landscape of multiple therapeutic and disease areas.

ALL RESOURCES
Resources

Blogs

Conference Reports

Infographics

Landscape Reviews

Market Reports

Webinars

Neuroscience

SfN Pre-Conference Featured Image

Date: 05/11/2025

SfN 2025 Pre-Conference Planner

View Article

2025 Neuroscience Landscape Review Feature Image

Date: 15/10/2025

Neuroscience 2025 Landscape Review

View Article

Date: 29/09/2025

6th Dry AMD & Geographic Atrophy Therapeutics Summit

View Article

Date: 29/09/2025

7th CNS Drug Delivery Summit

View Article

Date: 29/09/2025

3rd Fluid & Imaging Biomarkers in Neuroscience Summit

View Article

Beacon Neuroscience Thumbnail

Date: 12/08/2025

Beacon Neuroscience Database

View Article

Date: 11/08/2025

The Future of Neuroscience Drug Development: Opportunities and Challenges

View Article

Multiple Sclerosis Drug Development Landscape

Date: 21/07/2025

The Multiple Sclerosis Drug Development Landscape Report

View Article